𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple myeloma in younger patients: the role of age as prognostic factor

✍ Scribed by A. Corso; C. Klersy; M. Lazzarino; C. Bernasconi


Publisher
Springer
Year
1998
Tongue
English
Weight
161 KB
Volume
76
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic factors in multiple myeloma:
✍ Diem, H. ;Fateh-Moghadam, A. ;Lamerz, R. πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 722 KB

Serum [32-microglobulin , serum thymidine kinase, and commonly used prognostic parameters were investigated for their prognostic value in a well-defined group of patients with multiple myeloma (n = 207). Multivariate analysis showed hemoglobin to be the parameter of strongest prognostic value. Only

Proliferative activity of plasma cells i
✍ R. GarcΓ­a-Sanz; M.I. GonzΓ‘lez-Fraile; G. Mateo; J.M. HernΓ‘ndez; M.C. LΓ³pez-Berge πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 158 KB

## Abstract Although multiple myeloma (MM) is predominantly a disease of the elderly, few studies have focused on the identification of prognostic factors in this group of patients. Four hundred twenty five MM patients >65 years were uniformly treated with chemotherapy (MP or VCMP/VBAD). Multivaria

The prognostic value of soluble interleu
✍ Roberto Stasi; Maurizio Brunetti; Albertina Parma; Claudio Di Giulio; Edmondo Te πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

## Background: The effect of interleukin-6 (il-6), the major growth factor for myeloma cells, may be enhanced by soluble il-6 receptor (sil-6r). therefore, the current study investigated the clinical significance of serum sil-6r in patients with multiple myeloma (mm). ## Methods: Serum levels of